Wednesday, February 10, 2010, 11:38AM AEST - The Australian Stockmarket closes in 4 hours and 27 minutes.
To create a watchlist or portfolio of shares, Register

Warner Chilcott plc (WCRX)

8:00AM AEST: 25.51 USD  Up 0.30 (1.19%)  
 MORE ON WCRX 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Warner Chilcott plc (NasdaqNM:WCRX) Delayed quote dataEdit
Last Trade:25.51 USD
Trade Time: 8:00AM AEST
Change:Up 0.30 (1.19%)
Prev Close:25.21
Open:25.48
Bid:25.24 x 100
Ask:26.28 x 100
1y Target Est:30.72
Day's Range:25.22 - 25.88
52wk Range:9.24 - 29.24
Volume:1,048,245
Avg Vol (3m):1,726,400
Market Cap:6.41B
P/E (ttm):15.66
EPS (ttm):1.63
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add WCRX to Portfolio   Download Data

 HEADLINES 
Coverage initiated on Warner Chilcott by Oppenheimer
Briefing.com (Wed, Feb 3)
Another View: New Prism for Post-Crisis Deal Terms
at The New York Times (Wed, Feb 3)
Biotech Stocks: Drug stocks gain; Warner Chilcott climbs
at MarketWatch (Wed, Feb 3)
Biotech Stocks: Drug stocks hug flat line; Warner Chilcott climbs
at MarketWatch (Wed, Feb 3)
US STOCKS-Wall St rallies on ISM manufacturing data, Exxon
at Reuters (Tue, Feb 2)
US STOCKS SNAPSHOT-Wall St climbs on ISM, Exxon boost
at Reuters (Tue, Feb 2)
Biotech Stocks: Drug stocks gain; Warner Chilcott shares retreat
at MarketWatch (Tue, Feb 2)
Drug stocks gain; Warner Chilcott slides
at MarketWatch (Tue, Feb 2)
Warner Chilcott Sees 2010 EPS Above Views
at Fox Business (Sat, Jan 30)
Biotech Stocks: Warner Chilcott, Gilead, Sanofi gain ground
at MarketWatch (Sat, Jan 30)
More Headlines for WCRX...

 ANALYST 
EPS Est (next year) (Dec-09) :1.80
EPS Est (in 2 years) (Dec-10) :3.15
Avg Rec (current)*:1.8
PEG Ratio:5.22
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Warner Chilcott Limited, a specialty pharmaceutical company, engages in the development, manufacture, marketing, and sale of branded prescription pharmaceutical products in women’s healthcare and dermatology segments primarily in the United S...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices